» Articles » PMID: 20582455

Rapid Intradermal Delivery of Liquid Formulations Using a Hollow Microstructured Array

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2010 Jun 29
PMID 20582455
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this work is to demonstrate rapid intradermal delivery of up to 1.5 mL of formulation using a hollow microneedle delivery device designed for self-application.

Methods: 3M's hollow Microstructured Transdermal System (hMTS) was applied to domestic swine to demonstrate delivery of a variety of formulations including small molecule salts and proteins. Blood samples were collected after delivery and analyzed via HPLC or ELISA to provide a PK profile for the delivered drug. Site evaluations were conducted post delivery to determine skin tolerability.

Results: Up to 1.5 mL of formulation was infused into swine at a max rate of approximately 0.25 mL/min. A red blotch, the size of the hMTS array, was observed immediately after patch removal, but had faded so as to be almost indistinguishable 10 min post-patch removal. One-mL deliveries of commercial formulations of naloxone hydrochloride and human growth hormone and a formulation of equine anti-tetanus toxin were completed in swine. With few notable differences, the resulting PK profiles were similar to those achieved following subcutaneous injection of these formulations.

Conclusions: 3M's hMTS can provide rapid, intradermal delivery of 300-1,500 µL of liquid formulations of small molecules salts and proteins, compounds not typically compatible with passive transdermal delivery.

Citing Articles

Beyond the Needle: Innovative Microneedle-Based Transdermal Vaccination.

Nguyen H Medicines (Basel). 2025; 12(1).

PMID: 39982324 PMC: 11843882. DOI: 10.3390/medicines12010004.


Advancements in Skin-Mediated Drug Delivery: Mechanisms, Techniques, and Applications.

Lee D, Lim S, Kwak S, Kim J Adv Healthc Mater. 2023; 13(7):e2302375.

PMID: 38009520 PMC: 11468599. DOI: 10.1002/adhm.202302375.


Live-Attenuated VEEV Vaccine Delivered by iDNA Using Microneedles Is Immunogenic in Rabbits.

Tretyakova I, Tomai M, Vasilakos J, Pushko P Front Trop Dis. 2023; 3.

PMID: 37854093 PMC: 10583749. DOI: 10.3389/fitd.2022.813671.


Effects of Intradermal Administration Volume Using a Hollow Microneedle on the Pharmacokinetics of Fluorescein Isothiocyanate Dextran (M.W. 4,000).

Futaki M, Inamura K, Hashimoto M, Motegi S, Itakura S, Sugibayashi K Pharm Res. 2023; 40(8):1953-1963.

PMID: 37165148 DOI: 10.1007/s11095-023-03529-6.


Microneedle-Mediated Transdermal Delivery of Biopharmaceuticals.

Nguyen H, Nguyen C Pharmaceutics. 2023; 15(1).

PMID: 36678906 PMC: 9864466. DOI: 10.3390/pharmaceutics15010277.


References
1.
Nordquist L, Roxhed N, Griss P, Stemme G . Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control: an initial comparison with subcutaneous administration. Pharm Res. 2007; 24(7):1381-8. DOI: 10.1007/s11095-007-9256-x. View

2.
Liu M, Wittbrodt E . Low-dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Symptom Manage. 2002; 23(1):48-53. DOI: 10.1016/s0885-3924(01)00369-4. View

3.
Gupta J, Felner E, Prausnitz M . Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. Diabetes Technol Ther. 2009; 11(6):329-37. PMC: 2779563. DOI: 10.1089/dia.2008.0103. View

4.
Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y . Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine. 2008; 27(3):454-9. DOI: 10.1016/j.vaccine.2008.10.077. View

5.
Laurent P, Bonnet S, Alchas P, Regolini P, Mikszta J, Pettis R . Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine. 2007; 25(52):8833-42. DOI: 10.1016/j.vaccine.2007.10.020. View